September 29th, 2022 • Events Paysign is a Sponsor at Copay, Reimbursement and Access Congress Paysign is excited to be a sponsor at the upcoming Copay, Reimbursement, and Access Congress hybrid event in Philadelphi…
June 28th, 2022 • Blogs Exposing the Facts About Voucher and Bridge Pricing Our guest post, “Exposing the Facts About Voucher and Bridge Pricing”, was featured on Drug Channels, an est…
May 17th, 2022 • News• Uncategorized CMS 2023 Rule is Struck Down, Paysign Continues to Offer Innovation Paysign has an important update regarding the pending CMS Rule for 2023. Today, May 17, 2022, Judge Carl Nichols of the …
April 28th, 2022 • Blogs The False Promise of Current Drug Pricing Reforms The U.S. healthcare system has become a game of chess with each player strategizing their next move to stay in the game.…
April 20th, 2022 • Blogs What is the Final Price Rule According to the Centers for Medicare and Medic… Copay accumulator and maximizer programs continue to increase, creating new challenges for payers, manufacturers, and pa…
June 15th, 2021 • Blogs Pharmaceutical Manufacturers: The Importance of Creating Tailored Copay Solu… Access to medications, for some, can mean the literal difference between life and death. Stories of people skipping drug…
January 5th, 2021 • Blogs Understanding the Role of Pharmacy Hub Services In the U.S., the number of specialty pharmacies is on the rise, and hub services are growing in lockstep to meet the nee…
December 14th, 2020 • Blogs Protecting Patient Access to Care: The Cure for What Ails the Pharmaceutical… An Executive Insight on the 2021 Notice of Benefit Payment Parameters By Matthew Turner, VP of patient affordability sol…
